Physician
Endocrinology
Dr. Steven M. Haffner, MD
|
|
Give Review
Steven Haffner practices Endocrinology. He has 1 awards "Elected Member". Steven Haffner is a published doctor and has 100 publications published. The lastest was: 'Is a reduction in albuminuria associated with renal and cardiovascular protection? A post-hoc analysis of the ALTITUDE trial.'
Publications
- Is a reduction in albuminuria associated with renal and cardiovascular protection? A post-hoc analysis of the ALTITUDE trial.
- Serum pentadecanoic acid (15:0), a short-term marker of dairy food intake, is inversely associated with incident type 2 diabetes and its underlying disorders.
- Fasting and OGTT-Derived Measures of Insulin Resistance as Compared with the Euglycemic-Hyperinsulinemic Clamp in Non-diabetic Finnish Offspring of Type 2 Diabetic Ind...
- Chronic obstructive pulmonary disease and cardiovascular risk: Insights from the NAVIGATOR trial.
- Calcium and phosphate concentrations and future development of type 2 diabetes: the Insulin Resistance Atherosclerosis Study.
- Disproportionately elevated proinsulinemia is observed at modestly elevated glucose levels within the normoglycemic range.
- Impact of baseline physical activity and diet behavior on metabolic syndrome in a pharmaceutical trial: Results from NAVIGATOR.
- Risk of Developing Diabetes and Cardiovascular Disease in Metabolically Unhealthy Normal-Weight and Metabolically Healthy Obese Individuals.
- Differential white cell count and incident type 2 diabetes: the Insulin Resistance Atherosclerosis Study.
- Insulin Sensitivity and Insulin Clearance are Heritable and Have Strong Genetic Correlation in Mexican Americans.
- Predictors of Stroke in Patients With Impaired Glucose Tolerance: Results From the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research Trial.
- Lifestyle intervention and/or statins for the reduction of C-reactive protein in type 2 diabetes: From the look AHEAD study.
- Impact of differences in glucose tolerance on the prevalence of a negative insulinogenic index.
- A metabolically healthy obese phenotype in hispanic participants in the iras family study.
- Impaired Fasting Glucose and Impaired Glucose Tolerance Have Distinct Lipoprotein and Apolipoprotein Changes: The Insulin Resistance Atherosclerosis Study.
- Estimating the contributions of rare and common genetic variations and clinical measures to a model trait: adiponectin.
- The association of alanine aminotransferase within the normal and mildly elevated range with lipoproteins and apolipoproteins: the Insulin Resistance Atherosclerosis S...
- Adiponectin and the mediation of HDL cholesterol change with improved lifestyle: The Look AHEAD Study.
- Relationship of Insulin Sensitivity, Insulin Secretion, and Adiposity With Insulin Clearance in a Multiethnic Population: The Insulin Resistance Atherosclerosis Study.
- Impaired Glucose Tolerance and Obesity as Effect Modifiers of Ethnic Disparities of the Progression to Diabetes: The San Antonio Heart Study.
- Associations between surrogate measures of insulin resistance and waist circumference, cardiovascular risk and the metabolic syndrome across Hispanic and non-Hispanic ...
- Insulin secretion based on the late oral glucose tolerance test period and incident diabetes: the San Antonio Heart Study.
- Circulating Levels of TNF-? Are Associated with Impaired Glucose Tolerance, Increased Insulin Resistance, and Ethnicity: The Insulin Resistance Atherosclerosis Study.
- Insulin Resistance and Excess Risk of Diabetes in Mexican-Americans: The San Antonio Heart Study.
- Adiponectin and the Incidence of Type 2 Diabetes in Hispanics and African Americans: The IRAS Family Study.
- Cross-Sectional and Longitudinal Changes of Glucose Effectiveness in Relation to Glucose Tolerance: The Insulin Resistance Atherosclerosis Study.
- Relation of direct and surrogate measures of insulin resistance to cardiovascular risk factors in nondiabetic finnish offspring of type 2 diabetic individuals.
- Disposition index, glucose effectiveness, and conversion to type 2 diabetes: the Insulin Resistance Atherosclerosis Study (IRAS).
- A1C between 5.7 and 6.4% as a marker for identifying pre-diabetes, insulin sensitivity and secretion, and cardiovascular risk factors: the Insulin Resistance Atheroscl...
- Whole and refined grain intakes are related to inflammatory protein concentrations in human plasma.
- Variant in the 3' region of the IkappaBalpha gene associated with insulin resistance in Hispanic Americans: The IRAS Family Study.
- Performance characteristics of the new definition of diabetes: the insulin resistance atherosclerosis study.
- Insulin resistance, beta-cell dysfunction, and conversion to type 2 diabetes in a multiethnic population: the Insulin Resistance Atherosclerosis Study.
- Height, ethnicity, and the incidence of diabetes: the San Antonio Heart Study.
- Pulse pressure, prehypertension, and mortality: the San Antonio heart study.
- Genome-wide association study and follow-up analysis of adiposity traits in Hispanic Americans: the IRAS Family Study.
- Is prehypertension a risk factor for the development of type 2 diabetes?
- Association of plasma vitamin D levels with adiposity in Hispanic and African Americans.
- Association of 25-hydroxyvitamin D with blood pressure in predominantly 25-hydroxyvitamin D deficient Hispanic and African Americans.
- Adherence to the DASH Diet is inversely associated with incidence of type 2 diabetes: the insulin resistance atherosclerosis study.
- INSIG2 SNPs associated with obesity and glucose homeostasis traits in Hispanics: the IRAS Family Study.
- Dual renin-angiotensin system blockade and kidney disease.
- Association of SSTR2 polymorphisms and glucose homeostasis phenotypes: the Insulin Resistance Atherosclerosis Family Study.
- Correlates and heritability of nonalcoholic fatty liver disease in a minority cohort.
- Prediction of type 2 diabetes using alternate anthropometric measures in a multi-ethnic cohort: the insulin resistance atherosclerosis study.
- Changes in insulin sensitivity and insulin release in relation to glycemia and glucose tolerance in 6,414 Finnish men.
- Sleep duration as a risk factor for incident type 2 diabetes in a multiethnic cohort.
- Diabetes, abdominal adiposity, and atherogenic dyslipoproteinemia in women compared with men.
- Metabolic and antihypertensive effects of combined angiotensin receptor blocker and diuretic therapy in prediabetic hypertensive patients with the cardiometabolic synd...
- Determining the most appropriate components for a composite clinical trial outcome.
- Visceral fat and prevalence of hypertension among African Americans and Hispanic Americans: findings from the IRAS family study.
- Beta-cell dysfunction in subjects with impaired glucose tolerance and early type 2 diabetes: comparison of surrogate markers with first-phase insulin secretion from an...
- Relation of low glomerular filtration rate to metabolic disorders in individuals without diabetes and with normoalbuminuria.
- Quantitative trait analysis of type 2 diabetes susceptibility loci identified from whole genome association studies in the Insulin Resistance Atherosclerosis Family St...
- Evidence of interaction between PPARG2 and HNF4A contributing to variation in insulin sensitivity in Mexican Americans.
- Association of TCF7L2 gene polymorphisms with reduced acute insulin response in Hispanic Americans.
- Adiposity, the metabolic syndrome, and breast cancer in African-American and white American women.
- International Day for the Evaluation of Abdominal Obesity (IDEA): a study of waist circumference, cardiovascular disease, and diabetes mellitus in 168,000 primary care...
- Carotid intima-media thickness in confirmed prehypertensive subjects: predictors and progression.
- Abdominal adiposity and cardiometabolic risk: do we have all the answers?
- Is waist circumference an essential component of the metabolic syndrome?
- Alanine aminotransferase and directly measured insulin sensitivity in a multiethnic cohort: the Insulin Resistance Atherosclerosis Study.
- Associations of adiponectin with body fat distribution and insulin sensitivity in nondiabetic Hispanics and African-Americans.
- Which obesity index best explains prevalence differences in type 2 diabetes mellitus?
- Relationship of traditional and nontraditional cardiovascular risk factors to coronary artery calcium in type 2 diabetes.
- Change in body size and the risk of colorectal adenomas.
- Unmet needs in controlling metabolic disease.
- The National Cholesterol Education Program - Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic s...
- Haplotypes in the lipoprotein lipase gene influence fasting insulin and discovery of a new risk haplotype.
- Effect of pioglitazone compared with glimepiride on carotid intima-media thickness in type 2 diabetes: a randomized trial.
- The metabolic syndrome: risk factors and management.
- Relationship of metabolic risk factors and development of cardiovascular disease and diabetes.
- Physical activity in individuals at risk for diabetes: Diabetes Prevention Program.
- Risk constellations in patients with the metabolic syndrome: epidemiology, diagnosis, and treatment patterns.
- Progression of plasminogen activator inhibitor-1 and fibrinogen levels in relation to incident type 2 diabetes.
- The natural course of beta-cell function in nondiabetic and diabetic individuals: the Insulin Resistance Atherosclerosis Study.
- Trend in the prevalence of the metabolic syndrome and its impact on cardiovascular disease incidence: the San Antonio Heart Study.
- Geographic variations of the International Diabetes Federation and the National Cholesterol Education Program-Adult Treatment Panel III definitions of the metabolic sy...
- The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease.
- Prediction of type 2 diabetes mellitus with alternative definitions of the metabolic syndrome: the Insulin Resistance Atherosclerosis Study.
- Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study.
- The prevalence of the metabolic syndrome did not increase in Mexico City between 1990-1992 and 1997-1999 despite more central obesity.
- Association of proopiomelanocortin gene polymorphisms with obesity in the IRAS family study.
- Nuclear magnetic resonance lipoprotein abnormalities in prediabetic subjects in the Insulin Resistance Atherosclerosis Study.
- Re: "(Mis)use of factor analysis in the study of insulin resistance syndrome".
- Cosegregation of albuminuria and blood pressure: the Insulin Resistance Atherosclerosis (IRAS) family study.
- Cholesterol-lowering benefits of oat-containing cereal in Hispanic americans.
- Inflammation and cardiovascular disease in patients with diabetes: lessons from the Diabetes Control and Complications Trial.
- Lower hypertension risk in Mexico City than in San Antonio.
- Insulin resistance and adiposity influence lipoprotein size and subclass concentrations. Results from the Insulin Resistance Atherosclerosis Study.
- Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease?
- Comparison of the associations of apolipoprotein B and non-high-density lipoprotein cholesterol with other cardiovascular risk factors in patients with the metabolic s...
- Type 2 diabetes and the metabolic syndrome: National Cholesterol Education Program guidelines and supporting evidence.
- Metabolic and inflammation variable clusters and prediction of type 2 diabetes: factor analysis using directly measured insulin sensitivity.
- Insulin resistance and hypertension: the Insulin Resistance Atherosclerosis study.
- Using metabolic syndrome traits for efficient detection of impaired glucose tolerance.
- Differences in insulin resistance in nondiabetic subjects with isolated impaired glucose tolerance or isolated impaired fasting glucose.
- Insulin sensitivity, body fat distribution, and family diabetes history: the IRAS Family Study.
- Metabolic syndrome and diabetes mellitus.
Schools
Albert Einstein College of Medicine of Yeshiva University
Doctors Specialties
- Endocrinology
Accepted Insurances
Awards
- Elected Member
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1326372277 |
| Last Name Of The Provider | HAFFNER |
| First Name Of The Provider | STEVEN |
| View All |
Similar Doctors
|
|
Dr. Kathleen E. Hands, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jaime O. Cruz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gloria L. Ocampo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ramon Garza, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Edward A. Kohl, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tom J. Sauerwein, MD
This Doctor is OpenDoctor Recommended.
|